CFDE Workbench
DataKnowledgeCloudtrainingcoordination
CFDE Workbench

COL P04062-1 GLY 000888 (Collection)

Taxon:

Homo sapiens

Taxonomy (Entity type)
Protein:

GBA1 HUMAN

Protein (Entity type)
Project:

Portal

Project (Entity type)
Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)
Dcc:

GlyGen

DCC (Entity type)
Collection:

human proteoform glycosylation sites embl.csv

File (Entity type)
Anatomy:

kidney

Anatomy (Entity type)
Description:Information for protein P04062-1 in the context of file GLY_000888
Creation Time:2026-03-02 19:57:27.000000
Results found

Linked to

 

Label

Description

 

Compound

G11314AS

Compound (Entity type)

type="Composition" mass="1421.51788538" permass="1771.90913713" monosaccharides="8" is_motif="False"...

Protein

GBA1 HUMAN

Protein (Entity type)

Lysosomal acid glucosylceramidase (precursor)

Post Translational Modification

p04062-1 185asn 185asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p04062-1 58asn 58asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p04062-1 98asn 98asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p04062-1 309asn 309asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Compound

G55037KS

Compound (Entity type)

type="Composition" mass="2149.76662753" permass="2668.34568012" monosaccharides="11" is_motif="False...

Compound

G25059MC

Compound (Entity type)

type="Composition" mass="2718.9734452" permass="3377.70899849" monosaccharides="14" is_motif="False"...

  • Compound

    G11314AS

    Compound (Entity type)

    type="Composition" mass="1421.51788538" permass="1771.90913713" monosaccharides="8" is_motif="False"...

  • Protein

    GBA1 HUMAN

    Protein (Entity type)

    Lysosomal acid glucosylceramidase (precursor)

  • Post Translational Modification

    p04062-1 185asn 185asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Post Translational Modification

    p04062-1 58asn 58asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Post Translational Modification

    p04062-1 98asn 98asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Post Translational Modification

    p04062-1 309asn 309asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Compound

    G55037KS

    Compound (Entity type)

    type="Composition" mass="2149.76662753" permass="2668.34568012" monosaccharides="11" is_motif="False...

  • Compound

    G25059MC

    Compound (Entity type)

    type="Composition" mass="2718.9734452" permass="3377.70899849" monosaccharides="14" is_motif="False"...

    • DISPLAY PER PAGE
    CFDE Workbench
    Report a bug
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    @CFDE Workbench 2026
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    CFDE Workbench
    Report a bug
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    @CFDE Workbench 2026
    This repository is under review for potential modification in compliance with Administration directives.